Transversal Therapeutics
Biotechnology Research • 
Woburn, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 400 W Cummings Park, STE 5600, Woburn, MA 01801, US |
| Phone number | +17817597018 |
| Website | |
| NAICS | 541714 |
| Keywords | In-Vitro Diagnostics, Electrochemical Sensor Development, Rapid Quantitative Toxicology |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at Transversal Therapeutics
Christian Grenier
Director of Operations
About Transversal Therapeutics
Transversal’s electrochemical platform offers a versatile solution tailored to the diagnostic needs of both healthcare professionals and individuals. Demonstrated success in measuring salivary glucose and COVID-19 levels highlights our technology’s adaptability and potential. It can be developed into a wide range of sensors or panels, delivering competitive sensitivity and turnaround time at a fraction of the cost of leading point-of-care technologies. Our current projects focus on revolutionizing toxicology, where our sensors are uniquely positioned to enhance care for patients with opioid use disorder. By enabling providers to significantly improve treatment protocols, our best-in-class toxicology sensors deliver critical quantification in the context of single in-person visits. Importantly, these sensors serve as the foundation for a platform that accelerates the development of new sensors and panels for emerging challenges in toxicology and other fields.
Transversal Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Transversal Therapeutics has never raised funding before.
United Kingdom
CanadaFrequently asked questions
4.8
40,000 users
